Susan Blaney, M.D.
Picture
Positions
- The Elise C. Young Chair in Pediatric Oncology
-
Baylor College of Medicine
- Professor
-
Pediatrics
Hematology/Oncology
Baylor College of Medicine
Houston, TX USA
- Pediatric Cancer Program Leader
-
Dan L Duncan Comprehensive Cancer Center
Baylor College of Medicine
Houston, Texas United States
- Director
-
Texas Children's Cancer & Hematology Centers
Addresses
- Texas Children's Hospital, Clinical Care Center (Clinic)
-
6701 Fannin St
14th floor
Houston, TX 77030
United States
Phone: (832) 822-4242
Education
- Clinical Fellowship at Walter Reed Army Medical Center
- 06/1990 - Washington, District of Columbia United States
- Pediatric Hematology/Oncology
- Residency from Letterman Army Medical Center
- 06/1987 - San Francisco, California United States
- Pediatrics
- Internship at Tripler Army Medical Center
- 06/1985 - Honolulu, Hawaii United States
- Pediatrics
- M.D. from Medical College Of Ohio
- 06/1984 - Toledo, OH United States
- BS from Xavier University Ohio
- 06/1980 - Cincinnati, Ohio United States
- Chemistry
Honors & Awards
- Director
- Texas Children's Cancer and Hematology Centers
- The Elise C. Young Chair in Pediatric Oncology
- Professor of Pediatrics
- Baylor College of Medicine
Professional Interests
- Novel therapies for pediatric cancer
Websites
Selected Publications
- Yu L, Baxter PA, Voicu H, Gurusiddappa S, Zhao Y, Adesina A, Man TK, Shu Q, Zhang YJ, Zhao XM, Su JM, Perlaky L, Dauser R, Chintagumpala M, Lau CC, Blaney SM, Rao PH, Leung HC, Li XN "A clinically relevant orthotopic xenograft model of ependymoma that maintains the genomic signature of the primary tumor and preserves cancer stem cells in vivo.." Neuro-oncology. 2010 Jun;12(6):580-94. Pubmed PMID: 20511191
- Hummel TR, Wagner L, Ahern C, Fouladi M, Reid JM, McGovern RM, Ames MM, Gilbertson RJ, Horton T, Ingle AM, Weigel B, Blaney SM "A Pediatric Phase 1 Trial of Vorinostat and Temozolomide in Relapsed or Refractory Primary Brain or Spinal Cord Tumors: A Children's Oncology Group Phase 1 Consortium Study.." Pediatr Blood Cancer. 2013 Mar 28; Pubmed PMID: 23554030
- Souid AK, Dubowy RL, Ingle AM, Conlan MG, Sun J, Blaney SM, Adamson PC "A pediatric phase I trial and pharmacokinetic study of ispinesib: a Children's Oncology Group phase I consortium study.." Pediatr Blood Cancer. 2010 Dec 15;55(7):1323-8. Pubmed PMID: 20712019
- Sung C, Blaney SM, Cole DE, Balis FM, Dedrick RL "A pharmacokinetic model of topotecan clearance from plasma and cerebrospinal fluid.." Cancer Res.. 1994 Oct 1;54(19):5118-22. Pubmed PMID: 7923128
- Horton TM, Pati D, Plon SE, Thompson PA, Bomgaars LR, Adamson PC, Ingle AM, Wright J, Brockman AH, Paton M, Blaney SM "A phase 1 study of the proteasome inhibitor bortezomib in pediatric patients with refractory leukemia: a Children's Oncology Group study.." Clin. Cancer Res.. 2007 Mar 1;13(5):1516-22. Pubmed PMID: 17332297
- Jakacki RI, Bouffet E, Adamson PC, Pollack IF, Ingle AM, Voss SD, Blaney SM "A phase 1 study of vinblastine in combination with carboplatin for children with low-grade gliomas: a Children's Oncology Group phase 1 consortium study.." Neuro-oncology. 2011 Aug;13(8):910-5. Pubmed PMID: 21764821
- Baruchel S, Pappo A, Krailo M, Baker KS, Wu B, Villaluna D, Lee-Scott M, Adamson PC, Blaney SM "A phase 2 trial of trabectedin in children with recurrent rhabdomyosarcoma, Ewing sarcoma and non-rhabdomyosarcoma soft tissue sarcomas: a report from the Children's Oncology Group.." Eur. J. Cancer. 2012 Mar;48(4):579-85. Pubmed PMID: 22088484
- Geyer JR, Stewart CF, Kocak M, Broniscer A, Phillips P, Douglas JG, Blaney SM, Packer RJ, Gururangan S, Banerjee A, Kieran MW, Kun LE, Gilbertson RJ, Boyett JM "A phase I and biology study of gefitinib and radiation in children with newly diagnosed brain stem gliomas or supratentorial malignant gliomas.." Eur. J. Cancer. 2010 Dec;46(18):3287-93. Pubmed PMID: 20708924
- Lau L, Supko JG, Blaney S, Hershon L, Seibel N, Krailo M, Qu W, Malkin D, Jimeno J, Bernstein M, Baruchel S "A phase I and pharmacokinetic study of ecteinascidin-743 (Yondelis) in children with refractory solid tumors. A Children's Oncology Group study.." Clin. Cancer Res.. 2005 Jan 15;11(2):672-7. Pubmed PMID: 15701855
- Weigel BJ, Blaney SM, Reid JM, Safgren SL, Bagatell R, Kersey J, Neglia JP, Ivy SP, Ingle AM, Whitesell L, Gilbertson RJ, Krailo M, Ames M, Adamson PC "A phase I study of 17-allylaminogeldanamycin in relapsed/refractory pediatric patients with solid tumors: a Children's Oncology Group study.." Clin. Cancer Res.. 2007 Mar 15;13(6):1789-93. Pubmed PMID: 17363534
- Bomgaars L, Kerr J, Berg S, Kuttesch J, Klenke R, Blaney SM "A phase I study of irinotecan administered on a weekly schedule in pediatric patients.." Pediatr Blood Cancer. 2006 Jan;46(1):50-5. Pubmed PMID: 15768380
Log In to edit your profile
